3B Blackbio Dx Limited (NSE:3BBLACKBIO)
India · Delayed Price · Currency is INR 1,419.90
-23.40 (-1.62%)
At close: Sep 11, 2026
3B Blackbio Dx Company Description
3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India.
The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs.
It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
3B Blackbio Dx Limited
| Country | India |
| Founded | 1972 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 86 |
| CEO | Dhirendra Dubey |
Contact Details
Address: 7-C, Industrial Area Bhopal, 462023 India | |
| Phone | 91 75 5258 6536 |
| Website | 3bblackbio.com |
Stock Details
| Ticker Symbol | 3BBLACKBIO |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Dhirendra Kuber Dubey | Chairman and MD |
| Nikhil Kuber Dubey | Chief Financial Officer and Whole-Time Director |
| Navneet Kaur | Compliance Officer and Company Secretary |